Powered by BiozThis cell line is a modified version of iPS DF19-9-7T, genetically engineered by ZNFs to insert a DOX-inducible ETV2 construct into AAVS1 locus. Overexpression of ETV2 at different stages of differentiation can be used to study endothelial and hematopoietic specification from hPSCs. In addition, this cell line can be used to generate endothelial cells from hPSCs by treatment with doxycycline.
- Unit of Measure (UOM) vial
- Cell Type Modified Human iPS
- Sex Male
- Reprogramming Method Non-integrating (OCT4, SOX2, NANOG, LIN28, L-MYC, KLF4, SV40LT)
- Genetic Modification Keyword Reporter; Endothelial
- Disease None reported
- hPSCReg ID WAi001-B-1
- Provider University of Wisconsin - Dr. Igor Slukvin
- Collections Uncategorized
| Lot Number | Culture Platform | Lot Description | Banked By | Passage Number | Protocol | Product Info URL |
| WB67568 | TeSR-E8/Matrigel | WiCell | 7 | WiCell Feeder Independent Pluripotent Stem Cell Protocol |